Ticker
NWBOCompany Name
NORTHWEST BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
OTCDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 6.16M | $ 83.92M | $ -77.77M |
3/31/2025 | $ 4.69M | $ 83.06M | $ -78.37M |
12/31/2024 | $ 4.06M | $ 68.27M | $ -64.21M |
9/30/2024 | $ 5.19M | $ 59.56M | $ -54.37M |
6/30/2024 | $ 4.98M | $ 56.17M | $ -51.2M |
3/31/2024 | $ 4.95M | $ 62.44M | $ -57.49M |
12/31/2023 | $ 4.13M | $ 45.2M | $ -41.08M |
9/30/2023 | $ 8.45M | $ 49.22M | $ -40.77M |
6/30/2023 | $ 4.64M | $ 39.92M | $ -35.28M |
3/31/2023 | $ 9.49M | $ 44.71M | $ -35.22M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: AssetsC [ $ 12.18M ] - LiabilitesC [ $ 226.28M ]
(=) Working Capital [ $ -214.09M ]
Minimum
Dec 31, 2020
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 2.78K |
---|---|
min | $ -457.39M |
max | $ 607.04M |
average | $ 96.6M |
median | $ 32.21M |
std | $ 173.49M |